{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:43:12Z","timestamp":1761766992757,"version":"build-2065373602"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.hfc.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T14:12:59Z","timestamp":1635171179000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia"],"prefix":"10.1016","volume":"18","author":[{"given":"Emanuele","family":"Monda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Lioncino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Passantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Verrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annapaola","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelaide","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Di Fraia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Fimiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nunzia","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Mauriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Natale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioacchino","family":"Scarano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Girolami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Favilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5254","key":"10.1016\/j.hfc.2021.07.001_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.hfc.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jinorgbio.2018.03.007","article-title":"Interactions of iron-bound frataxin with ISCU and ferredoxin on the cysteine desulfurase complex leading to Fe-S cluster assembly","volume":"183","author":"Cai","year":"2018","journal-title":"J\u00a0Inorg Biochem"},{"issue":"5319","key":"10.1016\/j.hfc.2021.07.001_bib3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","article-title":"Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin","volume":"276","author":"Babcock","year":"1997","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.hfc.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich's ataxia","volume":"335","author":"D\u00fcrr","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2","article-title":"Clinical and genetic study of Friedreich ataxia in an Australian population","volume":"87","author":"Delatycki","year":"1999","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mds.26382","article-title":"Delayed-onset Friedreich's ataxia revisited","volume":"31","author":"Lecocq","year":"2016","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"10.1016\/j.hfc.2021.07.001_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","article-title":"Mortality in Friedreich ataxia","volume":"307","author":"Tsou","year":"2011","journal-title":"J\u00a0Neurol Sci"},{"issue":"9","key":"10.1016\/j.hfc.2021.07.001_bib8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/0883073812448230","article-title":"Clinical features of Friedreich ataxia","volume":"27","author":"Delatycki","year":"2012","journal-title":"J\u00a0Child Neurol"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/NEN.0b013e31827e5762","article-title":"Friedreich ataxia: neuropathology revised","volume":"72","author":"Koeppen","year":"2013","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/adc.59.3.217","article-title":"Friedreich's ataxia. A clinical review with neurophysiological and echocardiographic findings","volume":"59","author":"Ackroyd","year":"1984","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-010-0675-0","article-title":"Pathology and pathogenesis of sensory neuropathy in Friedreich's ataxia","volume":"120","author":"Morral","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-016-0288-5","article-title":"Dorsal root ganglia in Friedreich ataxia: satellite cell proliferation and inflammation","volume":"4","author":"Koeppen","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"10.1016\/j.hfc.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/NEN.0b013e31825fed76","article-title":"Skeletal muscle involvement in Friedreich ataxia and potential effects of recombinant human erythropoietin administration on muscle regeneration and neovascularization","volume":"71","author":"Nachbauer","year":"2012","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"7","key":"10.1016\/j.hfc.2021.07.001_bib14","first-page":"1114","article-title":"A\u00a0combined voxel-based morphometry and 1H-MRS study in patients with Friedreich's ataxia","volume":"256","author":"Fran\u00e7a","year":"2009","journal-title":"J\u00a0Neurol"},{"issue":"8","key":"10.1016\/j.hfc.2021.07.001_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1468-1331.2006.01363.x","article-title":"Exploring mental status in Friedreich's ataxia: a combined neuropsychological, behavioral and neuroimaging study","volume":"13","author":"Mantovan","year":"2006","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.001_bib16","doi-asserted-by":"crossref","first-page":"e0116396","DOI":"10.1371\/journal.pone.0116396","article-title":"The pathogenesis of cardiomyopathy in Friedreich ataxia","volume":"10","author":"Koeppen","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.hfc.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/mds.22864","article-title":"Analysis of the factors influencing the cardiac phenotype in Friedreich's ataxia","volume":"25","author":"Rajagopalan","year":"2010","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.001_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.001_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0317167100025464","article-title":"Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia","volume":"3","author":"Geoffroy","year":"1976","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13353-015-0331-4","article-title":"Friedreich ataxia is not only a GAA repeats expansion disorder: implications for molecular testing and counselling","volume":"57","author":"Hoffman-Zacharska","year":"2016","journal-title":"J\u00a0Appl Genet"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13023-019-1013-9","article-title":"Guidelines on the diagnosis and management of the progressive ataxias","volume":"14","author":"de Silva","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.hfc.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/eurheartj\/ehy798","article-title":"Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom","volume":"40","author":"Norrish","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"632293","DOI":"10.3389\/fped.2021.632293","article-title":"Hypertrophic cardiomyopathy in children: pathophysiology, diagnosis, and treatment of non-sarcomeric causes","volume":"9","author":"Monda","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.hfc.2021.07.001_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2019.06.073","article-title":"Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy","volume":"299","author":"Limongelli","year":"2020","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.hfc.2021.07.001_bib26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2015.1855","article-title":"A\u00a022-year follow-up study of long-term cardiac outcome and predictors of survival in Friedreich ataxia","volume":"72","author":"Pousset","year":"2015","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.hfc.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/mds.21590","article-title":"Cardiomyopathy in Friedreich's ataxia-assessment by cardiac MRI","volume":"22","author":"Meyer","year":"2007","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.001_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1253\/jcj.64.229","article-title":"Heart disease in Friedreich's ataxia: observation of a case for half a century","volume":"64","author":"Kawai","year":"2000","journal-title":"JPN Circ J"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0002-9149(97)89194-1","article-title":"The varying evolution of Friedreich's ataxia cardiomyopathy","volume":"77","author":"Casazza","year":"1996","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1016\/j.hfc.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.111.059477","article-title":"The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms","volume":"125","author":"Weidemann","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/hmg\/ddr554","article-title":"A\u00a0TAT-Frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model","volume":"21","author":"Vyas","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.001_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14734220600913246","article-title":"Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia","volume":"5","author":"Michael","year":"2006","journal-title":"Cerebellum"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.001_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","article-title":"Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia","volume":"9","author":"Bradley","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.hfc.2021.07.001_bib34","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.amjcard.2012.08.018","article-title":"Relation of cytosolic iron excess to cardiomyopathy of Friedreich's ataxia","volume":"110","author":"Ramirez","year":"2012","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.001_bib35","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0735-1097(86)80159-0","article-title":"Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients","volume":"7","author":"Child","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1540-8159.2009.02528.x","article-title":"Recurrent ventricular tachycardia in patient with Friedreich's ataxia in the absence of clinical myocardial disease","volume":"33","author":"Asaad","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.001_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehq443","article-title":"Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome","volume":"32","author":"Raman","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2021.07.001_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2015.05.074","article-title":"The cardiomyopathy in Friedreich's ataxia - new biomarker for staging cardiac involvement","volume":"194","author":"Weidemann","year":"2015","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.001_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/hrt.81.2.141","article-title":"Marked variation in the cardiomyopathy associated with Friedreich's ataxia","volume":"81","author":"Dutka","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2021.07.001_bib40","first-page":"e12813","article-title":"Electrocardiogram in Friedreich's ataxia: a short-term surrogate endpoint for treatment efficacy","volume":"5","author":"Mastroianno","year":"2020","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.001_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.amjcard.2011.09.025","article-title":"Analysis of echocardiograms in a large heterogeneous cohort of patients with Friedreich ataxia","volume":"109","author":"Regner","year":"2012","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/echo.12287","article-title":"Longitudinal strain in Friedreich ataxia: a potential marker for early left ventricular dysfunction","volume":"31","author":"St John Sutton","year":"2014","journal-title":"Echocardiography"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40001-016-0216-y","article-title":"Longitudinal strain bull's eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy","volume":"21","author":"Liu","year":"2016","journal-title":"Eur J Med Res"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.001_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ejhf.694","article-title":"Myocardial strain to detect subtle left ventricular systolic dysfunction","volume":"19","author":"Tops","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.001_bib45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/heartjnl-2018-314387","article-title":"Young adult with Friedreich ataxia","volume":"105","author":"Milano","year":"2019","journal-title":"Heart"},{"issue":"39","key":"10.1016\/j.hfc.2021.07.001_bib46","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.hfc.2021.07.001_bib47","first-page":"e558","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S104795111500013X","article-title":"Septal myectomy for hypertrophic obstructive cardiomyopathy in Friedreich's ataxia","volume":"26","author":"Anderson","year":"2016","journal-title":"Cardiol Young"},{"issue":"13","key":"10.1016\/j.hfc.2021.07.001_bib49","doi-asserted-by":"crossref","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.hfc.2021.07.001_bib50","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/0883073812448535","article-title":"Cardiomyopathy in Friedreich ataxia: clinical findings and research","volume":"27","author":"Payne","year":"2012","journal-title":"J\u00a0Child Neurol"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.001_bib51","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11845-012-0808-7","article-title":"Cardiomyopathy of Friedreich's ataxia (FRDA)","volume":"181","author":"Payne","year":"2012","journal-title":"Ir J Med Sci"},{"issue":"29","key":"10.1016\/j.hfc.2021.07.001_bib52","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.hfc.2021.07.001_bib53","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2018.10.043","volume":"74","author":"Kusumoto","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"27","key":"10.1016\/j.hfc.2021.07.001_bib54","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.hfc.2021.07.001_bib55","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2021.07.001_bib56","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13023-014-0184-7","article-title":"Consensus clinical management guidelines for Friedreich ataxia","volume":"9","author":"Corben","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.hfc.2021.07.001_bib57","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/mds.25058","article-title":"A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial","volume":"27","author":"Lynch","year":"2012","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.hfc.2021.07.001_bib58","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/jimd.12285","article-title":"Safety and efficacy of (+)-epicatechin in subjects with Friedreich's ataxia: a phase II, open-label, prospective study","volume":"44","author":"Qureshi","year":"2021","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"11","key":"10.1016\/j.hfc.2021.07.001_bib59","first-page":"2170","article-title":"Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia","volume":"263","author":"Costantini","year":"2016","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/acn3.660","article-title":"Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia","volume":"6","author":"Lynch","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.001_bib61","first-page":"1344","article-title":"An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels","volume":"262","author":"Yiu","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.001_bib62","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-004-0216-x","article-title":"L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial","volume":"112","author":"Sch\u00f6ls","year":"2005","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.001_bib63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ana.24248","article-title":"Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial","volume":"76","author":"Pandolfo","year":"2014","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12311-010-0212-7","article-title":"Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia","volume":"10","author":"Velasco-S\u00e1nchez","year":"2011","journal-title":"Cerebellum"},{"issue":"1","key":"10.1016\/j.hfc.2021.07.001_bib65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ane.12141","article-title":"Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial","volume":"129","author":"Arpa","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.hfc.2021.07.001_bib66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2217\/nmt-2018-0013","article-title":"Double-blind, randomized and controlled trial of EPI-743 in Friedreich's ataxia","volume":"8","author":"Zesiewicz","year":"2018","journal-title":"Neurodegener Dis Manag"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.001_bib67","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/mds.27353","article-title":"Randomized, clinical trial of RT001: early signals of efficacy in Friedreich's ataxia","volume":"33","author":"Zesiewicz","year":"2018","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2021.07.001_bib68","first-page":"25","article-title":"Idebenone: an emerging therapy for Friedreich ataxia","volume":"256","author":"Meier","year":"2009","journal-title":"J\u00a0Neurol"},{"issue":"9177","key":"10.1016\/j.hfc.2021.07.001_bib69","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(99)01341-0","article-title":"Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study","volume":"354","author":"Rustin","year":"1999","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.hfc.2021.07.001_bib70","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","article-title":"Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial","volume":"6","author":"Di Prospero","year":"2007","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.hfc.2021.07.001_bib71","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archneurol.2010.168","article-title":"A\u00a0phase 3, double-blind, placebo-controlled trial of idebenone in Friedreich ataxia","volume":"67","author":"Lynch","year":"2010","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.hfc.2021.07.001_bib72","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ahj.2010.10.038","article-title":"Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA)","volume":"161","author":"Lagedrost","year":"2011","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.hfc.2021.07.001_bib73","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/ane.13088","article-title":"Patient-reported outcomes in Friedreich's ataxia after withdrawal from idebenone","volume":"139","author":"Cook","year":"2019","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.hfc.2021.07.001_bib74","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm.3510","article-title":"Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia","volume":"20","author":"Perdomini","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.hfc.2021.07.001_bib75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5348\/ijcri-201503-CS-10054","article-title":"A\u00a0novel approach of human embryonic stem cells therapy in treatment of Friedrich's Ataxia","volume":"6","author":"Shroff","year":"2015","journal-title":"Int J Case Rep Images"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713621000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713621000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:42:20Z","timestamp":1761554540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713621000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1551713621000702"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2021.07.001","relation":{},"ISSN":["1551-7136"],"issn-type":[{"type":"print","value":"1551-7136"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}